 |
市場調査レポート
世界のドラッグデリバリーシステム市場Global Pharmaceutical Drug Delivery System Market 2019 - 2025 |
||||||
| 発行 | Orion Market Research Pvt Ltd | 商品コード | 911639 | ||||
| 出版日 | ページ情報 | 英文 納期: 2-3営業日 |
|||||
| 価格 |
|
||||||
| 世界のドラッグデリバリーシステム市場 Global Pharmaceutical Drug Delivery System Market 2019 - 2025 | ||
| 出版日: 2019年08月23日 | ページ情報: 英文 |
|
当レポートは世界のドラッグデリバリーシステム市場について調査しており、市場機会、成長および阻害要因、投与経路・用途・エンドユーザー・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。
Title:
Global Pharmaceutical Drug Delivery System
Market Size, Share & Trends Analysis Report by Route of Administration (Injectable Drug Delivery, Topical Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, and Others), by Application (Infectious Diseases, Cancer, Cardiovascular Diseases (CVDs), Diabetes, Nervous System Disorders, Respiratory Diseases, and Others), by End-User (Hospitals & Clinics, Ambulatory Surgery Centers (ASCs), Homecare, and Diagnostic Centers) and Forecasts, 2019 - 2025.
The global pharmaceutical drug delivery system market is expected to register significant growth over the forecast period. The growth of the market is primarily driven by the rising prevalence of chronic diseases. Moreover, growth in the biologics market coupled with technological advancements and new product launch is also augmenting the market growth in recent years. The global pharmaceutical drug delivery system market is segmented on the basis of the route of administration, application, end-user, and region.
The market, on the basis of route of administration, is further segmented into injectable drug delivery, topical drug delivery, pulmonary drug delivery, nasal drug delivery, and others. Among these, topical drug delivery offers various advantages such as convenience and ease of use, painless and noninvasive delivery, and enhanced patient compliance. Further, on the basis of application, the market is segmented into infectious diseases, cancer, CVDs, diabetes, nervous system disorders, respiratory diseases, and others. On the basis of end-user, the market is segmented into hospitals and clinics, ASCs, homecare, and diagnostic centers. Among these, pharmaceutical drug delivery in hospitals and clinics market is expected to contribute significantly due to an increase in the number of inpatient and outpatient visits to hospitals for the treatment of various chronic diseases.
Geographically, the report analyzes the market into North America, Europe, Asia-Pacific, and Rest of the World. North America is expected to have the largest market size in the global pharmaceutical drug delivery system market. The market growth is attributed to the presence of a large number of prominent players such as 3M Co., Boston Scientific Corp., and Becton Dickinson and Co. In addition, the region has well-established healthcare infrastructure, which further gives a boost to the growth of the market in North America. Moreover, Asia-Pacific is expected to exhibit a considerable growth rate during the forecast period. The market growth is attributed to increasing population pool with aged people coupled with the rise in prevalence of chronic diseases.
The global pharmaceutical drug delivery system market consists of several players operating in the market. Some of the players in the market include Johnson & Johnson, F. Hoffman-La Roche Ltd., Merck KGaA, Bayer AG, Pfizer, Inc., Novartis AG, GlaxoSmithKline PLC, 3M Co., Becton, Dickinson and Co., and Antares Pharma, Inc., among others. Novartis AG is one of the leading players in the global pharmaceutical drug delivery system market. The company adopts several organic and inorganic growth strategies, such as partnerships and collaborations and new product launches to maintain its leading position in the market. For instance, in 2018, Novartis established a partnership with Gan & Lee (China) for the commercialization and supply of biosimilar versions of insulins (glargine, lispro, and aspart), used in patients with type 1 and type 2 diabetes. With this partnership, the company is aimed at strengthening its customer base in different geographical regions.
The market study of the global pharmaceutical drug delivery system market is incorporated by extensive primary and secondary research conducted by a research team at OMR. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macroeconomic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.
The report is intended for pharmaceutical companies, medical device manufacturers, healthcare providers, academic and research institutes, potential start-ups, investors and venture capitalists, and government organizations for overall market analysis and competitive analysis. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.
